This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Curious about which cash back credit cards don't charge an annual fee? Discover options that allow you to earn rewards without extra costs.
26,317 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Investors are watching limoneira (lmnr) 2026 earnings for clues on citrus demand, real estate activity, and cost mana...
Broadcom’s AI demand story is stirring a lot of chatter in markets. This article breaks down what the CEO’s remarks c...
Two Harbors moved its special meeting to July 2 to push the CrossCountry Mortgage deal through, while a rival bid fro...
This deep dive breaks down alto 2025 earnings, focusing on Q4 results, revenue growth, and what management signals fo...
The trillion-dollar club is expanding, and a few ahead-of-the-curve signals can help you spot the next member. This g...
A stock can jump this year, but chasing it blindly rarely ends well. This guide helps you assess whether the move jus...
Mortgage rates 6.5% can slow momentum, but they don’t stop your investing goals. This guide delivers six practical mo...
If you’re worried about stock market volatility, a proven dividend stock can be your anchor. This guide explains why ...
A comprehensive, reader-friendly analysis of CVV's Q4 2025 earnings transcript. Learn how revenue trends, margins, an...
When Netflix reportedly missed out on Roku, investors asked: what does this mean for the company’s future profits and...
Palantir has slipped significantly from its all-time high, prompting questions about a buy-the-dip opportunity. This ...